Table 1.

Comparison of clinical data

Clinical Data	Gender		Age (years)	Duration of Disease (years)	Body Mass Index (kg/m2)	Disease Stage
	Male	Female				I	II	III
Early SGLT2-i group (n = 88)	38	50	66.48±3.19	6.89±0.87	23.20±1.12	33	31	24
Late SGLT2-i group (n = 90)	41	49	65.55±3.26	7.12±0.84	22.87±1.28	36	27	27
χ2/Z	0.102		1.94	1.757	1.823	0.560
P	0.750		0.054	0.081	0.070	0.756

SGLT2-i, sodium-glucose cotransporter 2 inhibitor.